VeriMom¿Es oligopeptide-106 seguro durante el embarazo?
No harmonised CLP classification or SCCS/CIR safety assessment was identified for 'oligopeptide-106', and no peer‑reviewed reproductive toxicity or endocrine‑activity data are available in the major databases. Peptides used in cosmetics are generally high‑molecular‑weight and have low dermal absorption, so there is no evidence of a reproductive hazard under cosmetic use conditions (sources checked: ECHA Annex VI, SCCS/CIR listings, PubMed, CosIng, PubChem).
Related ingredients
Frequently asked questions
- ¿Es oligopeptide-106 seguro durante el embarazo?
- No harmonised CLP classification or SCCS/CIR safety assessment was identified for 'oligopeptide-106', and no peer‑reviewed reproductive toxicity or endocrine‑activity data are available in the major databases. Peptides used in cosmetics are generally high‑molecular‑weight and have low dermal absorption, so there is no evidence of a reproductive hazard under cosmetic use conditions (sources checked: ECHA Annex VI, SCCS/CIR listings, PubMed, CosIng, PubChem).
- ¿Es oligopeptide-106 seguro durante la lactancia?
- No data indicating reproductive or lactation hazards, no harmonised classification, and no mechanistic evidence for transfer into breast milk or effects on lactation were identified. Given the lack of adverse signals and expected low dermal/systemic absorption of cosmetic peptides, risk is not indicated for breastfeeding (sources checked: ECHA Annex VI, CIR, PubMed, CosIng, PubChem).
- ¿Es oligopeptide-106 seguro para la piel del bebé?
- No hazard or mechanistic data specific to infants were found. Adult dermal absorption is expected to be negligible for oligopeptides used in cosmetics (adult exposure scored 0), but because infant skin has a less mature barrier and higher surface‑area/weight, exposure scoring is increased by +1 to reflect potentially higher, low but measurable exposure in 0–3‑year‑olds. There is no infant‑specific toxicity evidence to increase hazard or mechanism scores (sources checked: CosIng, PubMed, ECHA Annex VI, PubChem).
- ¿Cómo puntúa VeriMom a oligopeptide-106?
- VeriMom puntúa oligopeptide-106 en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a oligopeptide-106 en el embarazo?
- Consulta nuestra lista de alternativas seguras a oligopeptide-106 según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.